Jump to section
To solve the global supply/demand problem in psychotherapy
The COVID-19 pandemic has sharply accelerated the rise in mental health problems, and more UK citizens than ever are seeking out healthcare solutions. This increase in patient demand, however, is outpacing the clinical capacity for care, which has resulted in an overburdened and underfunded mental healthcare field facing growing backlogs. Limbic AI is a startup looking to address this shortfall, offering a suite of conversational AI products to support patients and clinicians throughout the mental healthcare pathway.
Their products collect data to ease the admin load for professionals, facilitate faster diagnoses, and improve patient access to NICE-approved therapies. It’s won them good engagement so far, Limbic already covers 180,000 annual patient referrals, works with 15% of NHS talk therapy providers, and has garnered a number of awards for its efforts. Funding is being used to expand the availability of its product into US markets.
Freddie
Company Specialist at Welcome to the Jungle
Mar 2024
$14m
SERIES A
Dec 2021
$0.2m
SERIES A
This company has top investors
Sebastiaan de Vries
(CTO)Always been building things since a young age. Fell in love with programming at 16 and haven't stopped making digital products since. Previous to Limbic I built the best-rated p2p payments in NL.
Ross Harper
(CEO)Did a PhD in computational neuroscience at UCL after which I joined Entrepreneur First to help tackle one of the biggest challenges of our generation. I also have a dog named Theo.